Skip to main content

Celularity Inc

CELU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001752828

No open-market purchases or sales by Celularity Inc insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $2.44M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Celularity Inc changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of CELU: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders3438+4
Shares2.18M2.30M+122.0K (+5.6%)
Value$4.27M$4.76M+$488.0K (+11.4%)

New holders (8)

Institutions that held Celularity Inc at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to CELU in Q3 2025
InstitutionSharesValue% of portfolio
HB Wealth Management, LLC40,415$83.7K0.00%
Susquehanna International Group, LLP26,410$54.7K0.00%
HRT Financial LP16,062$33.0K0.00%
Groupe la Francaise17,000$31.1K0.00%
Perennial Investment Advisors, LLC13,629$28.2K0.00%
Caldwell Sutter Capital, Inc.1,000$2.07K0.00%
Wells Fargo & Company500$1.03K0.00%
United Financial Planning Group LLC19$390.00%

Sold out (4)

Institutions that held Celularity Inc at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of CELU in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Group One Trading, L.P.25,173$49.3K
XTX Topco Ltd21,452$42.0K
Acadian Asset Management LLC12,565$24.0K
Raymond James Financial Inc100$196